Literature DB >> 19092300

Cardiovascular aspects of primary hyperparathyroidism.

M D Walker1, S J Silverberg.   

Abstract

Data concerning the cardiovascular manifestations of primary hyperparathyroidism (PHPT) are inconsistent, which is due, in part, to the decrease in disease severity over the last several decades. In areas where patients tend to be more symptomatic, data support the presence of cardiovascular findings including myocardial and vascular calcification as well as increased cardiovascular mortality. Data from the cohorts in whom the disease is characterized by mild hypercalcemia, suggest that clinically overt cardiovascular manifestations are unusual in PHPT. Recent data, however, support the presence of subtle cardiovascular manifestations in mild disease, such as changes in endothelial function as well as increased vascular stiffness and perhaps diastolic dysfunction. Left ventricular hypertrophy is a more consistent finding across a spectrum of disease severity, though this finding may be related to hypertension, which has long been associated with PHPT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092300      PMCID: PMC6056175          DOI: 10.1007/BF03346443

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  68 in total

1.  Arterial stiffness in mild primary hyperparathyroidism.

Authors:  Mishaela R Rubin; Mathew S Maurer; Donald J McMahon; John P Bilezikian; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

2.  Longitudinal studies of mild primary hyperparathyroidism.

Authors:  S Ljunghall; S Jakobsson; C Joborn; M Palmér; J Rastad; G Akerström
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

3.  Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

Authors:  C Fardella; J A Rodriguez-Portales
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

4.  Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.

Authors:  A Piovesan; N Molineri; F Casasso; I Emmolo; G Ugliengo; F Cesario; G Borretta
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

5.  Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism.

Authors:  Inga-Lena Nilsson; Jan Aberg; Jonas Rastad; Lars Lind
Journal:  Surgery       Date:  2005-06       Impact factor: 3.982

6.  Causes of death in patients previously operated on for primary hyperparathyroidism.

Authors:  H Ronni-Sivula
Journal:  Ann Chir Gynaecol       Date:  1985

7.  Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy.

Authors:  T Stefenelli; H Mayr; J Bergler-Klein; S Globits; W Woloszczuk; B Niederle
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

8.  Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy.

Authors:  Erik G Almqvist; Anne-Greth Bondeson; Lennart Bondeson; Anders Nissborg; Peter Smedgård; Sven-Eric Svensson
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

9.  Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

Authors:  C Symons; F Fortune; R A Greenbaum; P Dandona
Journal:  Br Heart J       Date:  1985-11

10.  Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.

Authors:  Elena Kamycheva; Johan Sundsfjord; Rolf Jorde
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-02
View more
  18 in total

1.  Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging.

Authors:  Cecilia Marini; Massimo Giusti; Riccardo Armonino; Giorgio Ghigliotti; GianPaolo Bezante; Lara Vera; Silvia Morbelli; Elena Pomposelli; Michela Massollo; Patrizia Gandolfo; Francesco Minuto; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-04       Impact factor: 9.236

2.  The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Melia Karakose; Mustafa Caliskan; Muyesser Sayki Arslan; Taner Demirci; Suleyman Karakose; Erman Cakal
Journal:  Endocrine       Date:  2016-11-14       Impact factor: 3.633

3.  Calcium supplementation and risk of dementia in women with cerebrovascular disease.

Authors:  Jürgen Kern; Silke Kern; Kaj Blennow; Henrik Zetterberg; Margda Waern; Xinxin Guo; Anne Börjesson-Hanson; Ingmar Skoog; Svante Östling
Journal:  Neurology       Date:  2016-08-17       Impact factor: 9.910

4.  Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Marcella D Walker; Elaine Cong; Anna Kepley; Marco R Di Tullio; Tatjana Rundek; Shunichi Homma; James A Lee; Rui Liu; Polly Young; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

5.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

6.  Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer's Disease.

Authors:  Ling-Zhi Ma; Zi-Xuan Wang; Zuo-Teng Wang; Xiao-He Hou; Xue-Ning Shen; Ya-Nan Ou; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Neurotox Res       Date:  2020-11-20       Impact factor: 3.911

7.  Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy.

Authors:  P Farahnak; M Ring; K Caidahl; L-O Farnebo; M J Eriksson; I-L Nilsson
Journal:  Eur J Endocrinol       Date:  2010-06-18       Impact factor: 6.664

Review 8.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

Review 9.  Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Authors:  Federico Carbone; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2014-05-26

Review 10.  Medial vascular calcification revisited: review and perspectives.

Authors:  Peter Lanzer; Manfred Boehm; Victor Sorribas; Marc Thiriet; Jan Janzen; Thomas Zeller; Cynthia St Hilaire; Catherine Shanahan
Journal:  Eur Heart J       Date:  2014-04-16       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.